Tumor necrosis factor-α stimulates adrenal glucocorticoid secretion in cholestatic rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 270, Issue 6 33-6, 1996, Pages

  Swain, Mark G ^a,b,c   Maric, Mirjana ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b Med Res Council of Canada Scholar   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

cytokine; neuroendocrine immune hypothalamic pituitary adrenal axis

Indexed keywords

ENDOTOXIN; GLUCOCORTICOID; INTERLEUKIN 1; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; CHOLESTASIS; CONTROLLED STUDY; HORMONE BLOOD LEVEL; HYPOPHYSECTOMY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEROID RELEASE; STEROIDOGENESIS;

EID: 0029803285     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1996.270.6.g987     Document Type: Article

References (30)

1. Abernathy, R. S., F. Halberg, and W. W. Spink. Studies on the mechanism of chlorpromazine protection against Brucella endotoxin in mice. J. Lab. Clin. Med. 49: 708-712, 1957.
2. Bateman, A., A. Singh, T. Kral, and S. Soloman. The immune-hypothalamic-adrenal axis. Endocrine Rev. 10: 92-112, 1989.
3. Bemelmans, M. H. A., D. J. Gouma, J. W. Greve, and W. A. Buurman. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology Baltimore 15: 1132-1136, 1992.
4. Bemelmans, M. H. A., D. J. Gouma, J. W. Greve, and W. A. Buurman. Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice. Br. J. Surg. 80: 1055-1058, 1993.
5. Bernardinini, R., T. C. Kamilaris, A. E. Calogero, E. O. Johnson, M. T. Gomez, P. W. Gold, and G. P. Chrousos. Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 126: 2876-2881, 1990.
6. Bertini, R., M. Bianchi, and R. Ghezzi. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167: 1708-1712, 1988.
7. Beutler, B., and A. Cerami. Tumour necrosis, cachexia, shock and inflammation: a common mediator. Annu. Rev. Biochem. 57: 506-518, 1988.
8. Beutler, B., J. W. Milsark, and A. Cerami. Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effect of endotoxin. Science Wash. DC 229: 869-871, 1985.
9. Cameron, G. R., and C. L. Oakley. Ligation of the common bile duct. J. Pathol. Bacteriol. 35: 769-798, 1932.
10. Clements, B., I. Halliday, P. Irwin, M. McCaigue, and B. J. Rowlands. Decreased Kupffer cell clearance capacity (KCCC) contributes to endotoxemia seen in cholestasis (Abstract). Gut 33: W78, 1991.
11. Debets, J. M. H., R. Kampmeijer, M. P. M. H. van der Linden, W. A. Buurman, and C. J. van der Linden. Plasma tumour necrosis factor and mortality in critically ill septic patients. Crit. Care Med. 17: 489-494, 1989.
12. 2-Met-enkephalinamide, a potent opioid peptide, alters pituitary-adrenocortical secretion in rats. Endocrinology 111: 1483-1490, 1982.
13. Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145: 3762-3766, 1990.
14. Greve, J. W., D. J. Gouma, P. B. Soeters, and W. A. Buurman. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ free rats. Gastroenterology 98: 478-485, 1990.
15. Greve, J. W., J. G. Maessen, T. Tiebosch, W. A. Buurman, and D. J. Gouma. Prevention of postoperative complications in jaundiced rats. Ann. Surg. 212: 221-227, 1990.
16. Gwosdow, A. R., M. S. A. Kumar, and H. H. Bode. Interleukin-1 stimulation of the hypothalamic-pituitary-adrenal axis. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E65-E70, 1990.
17. Kunkel, S. L., D. G. Remick, R. M. Strieter, and J. W. Larrick. Mechanisms that regulate the production and effects of tumour necrosis factor-α. Crit. Rev. Immunol. 9: 93-117, 1989.
18. Magez, S., R. Lucas, A. Darji, E. B. Songa, R. Hamers, and P. De Baetselier. Murine tumour necrosis factor plays a protective role during the initial phase of the experimental infection with Trypanosoma brucei brucei. Parasite Immunol. Oxf. 15: 635-641, 1993.
19. Melby, J. C., and W. W. Spink. Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection. J. Clin. Invest. 37: 1791-1798, 1958.
20. Morano, M. A., Y. Fong, L. L. Moldawer, H. Wei, S. E. Calvano, K. J. Tracey, P. S. Barie, K. Monogue, A. Cerami, G. T. Shires, and S. F. Lowry. Serum cachetin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg. Gynecol. Obstet. 170: 32-38, 1990.
21. Munck, A., P. M. McGuyre, and N. J. Holbrook. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5: 25-44, 1984.
22. Natanson, C., W. D. Hoffman, A. F. Suffredini, P. Q. Eichacker, and R. L. Danner. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Int. Med. 120: 771-783, 1994.
23. Sharp, B. M., S. G. Matta, P. K. Peterson, R. Newton, C. Chao, and K. McAllen. Tumor necrosis factor-alpha is a potent ACTH secretogogue: comparison to interleukin-1 beta. Endocrinology 124: 3131-3133, 1989.
24. Sibbald, W. J., A. Short, M. P. Cohen, and R. F. Wilson. Variations in adrenocortical responsiveness during severe bacterial infections. Ann. Surg. 186: 29-33, 1977.
25. 2 release. Am. J. Physiol. 268 (Gastrointest. Liver Physiol. 31): G404-G409, 1995.
26. Swain, M. G., V. Patchev, J. Vergalla, G. Chrousos, and E. A. Jones. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. J. Clin Invest. 91: 1903-1908, 1993.
27. Tilg, H., A. Wilmer, W. Vogel, M. Herold, B. Nolchen, G. Judmaier, and C. Huber. Serum levels of cytokines in chronic liver diseases. Gastroenterology 103: 264-274, 1992.
28. Tominaga, T., J. Fukata, Y. Naito, T. Usui, N. Murakami, M. Fukushima, Y. Nakai, Y. Hirai, and H. Imura. Prostaglandin-dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins. Endocrinology 128: 526-531, 1991.
29. Van Der Poll, T., and H. P. Sauerwein. Tumour necrosis factor-alpha: its role in the metabolic response to sepsis. Clin. Sci. Lond. 84: 247-264, 1993.
30. Zuckerman, S. H., J. Shellhaas, and L. D. Butler. Differential regulation of lipopolysaccharide-induced interleukin-1 and tumour necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur. J. Immunol. 19: 301-305, 1989.